30

nanotimes

Companies Facts

In connection with the Tender Offer, Headwaters is also soliciting consents (“Consents”) from the holders of the Notes for certain proposed amendments to the indenture governing the Notes (the “Consent Solici- tation”). Holders that validly tender their Notes will be deemed to have delivered their Consent to the proposed amendments. Holders may not tender their Notes without delivering their Consents to the propo- sed amendments and may not deliver their Consents without tendering their Notes. The primary purpose of the Consent Solicitation and the proposed amend- ments is to eliminate substantially all of the restrictive covenants and certain events of default.

On March 08, 2011, Headwaters announced the pricing of its offering of $400.0 million aggregate principal amount of 7-5/8% Senior Secured Notes due 2019 (the “Notes”). The Notes will be senior secured obligations of Headwaters and will be gua- ranteed by certain of Headwaters’ existing and future domestic subsidiaries. The offering is expected to close on March 11, 2011, subject to certain closing conditions. Headwaters expects net proceeds from the offering to be approximately $393.3 million (after deducting the initial purchasers’ commissions and estimated transaction fees and expenses).

Headwaters intends to use the net proceeds to fund the previously announced tender offer for any and all of its $328.3 million aggregate principal amount of 11-3/8% Senior Secured Notes due 2014 outstan- ding (the “11-3/8% Notes”) and to pay related tender premiums and transaction fees and expenses. Furthermore, the Company announced that coal ash produced at the Virginia City Hybrid Energy Center will be managed by a subsidiary of Headwaters In- corporated. Headwaters is America‘s largest manager

I

11-02/03 :: February / March 2011

BM’s (NYSE: IBM) announcement of the first biodegradable nanoparticles that can seek

out and destroy drug-resistant bacteria caps off a century of healthcare and life sciences innova- tion from IBM. Earlier this week, scientists from IBM Research announced ground breaking early research discovering new types of nanoparti- cles that are physically attracted like magnets to MRSA cells, ignoring healthy cells completely and targeting and killing the bacteria by poking holes in its walls. This discovery could greatly improve the effectiveness of medication. This innovation is just one example of IBM’s ability to use principles and technologies from computing, physics, mate- rials science and chemistry to advance the science of medicine.

http://www.ibm.com http://www.youtube.com/ibmhealthcare

and marketer of coal combustion products – under a long-term contract recently signed with the plant owner, Dominion Virginia Power. The 585-mega- watt power plant is currently under construction in